| What it does | AI-powered peptide safety analysis against published evidence
| Plain answers to health questions for people managing cancer or chronic conditions
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2023
|
|---|
| Based in | Not given
| US
|
|---|
| Pricing model | Paid
| Freemium
|
|---|
| Pricing | Starter: $15/mo (100 checks/month, 1 stack). Pro: $19/mo (125 checks/month, 3 stacks, stack interaction analysis, PDF export). Clinic: $25/mo (165 checks/month, 10 stacks, stack interaction analysis, PDF export, priority support). Weekly and monthly billing cycles available.
| 7-day free trial (card required to start), then $9 per month. Membership includes record requests through national networks, uploads, plain-language reading and physician-reviewed analysis. Cancel any month.
|
|---|
| Key features | - AI-powered safety scoring weighted by study design and sample size
- Regulatory status lookup for US FDA approvals and investigational status
- Peptide stack builder with dosing calendar and adherence tracking
- Stack interaction analysis across multiple compounds
- PDF export of full reports
- Mobile app label scanning capability
- Real-time evidence retrieval from three primary sources
- Risk flag identification for specific peptides
| - Consolidates medical records from multiple healthcare providers
- Integrates wearable data (Fitbit, Garmin, Oura, Whoop, Withings, Dexcom)
- Analyzes raw sequencing data with established genomic tools
- Organizes records by condition with longitudinal timeline
- Physician-reviewed deeper analysis before delivery
- Plain-language reading of medical records
- Generates questions prepared for doctor appointments
- Connects to medical records via Carequality and TEFCA networks
- Free public tools for cancer survival, phase 1 trials and advocacy groups
- HIPAA compliant with encryption in transit and at rest
|
|---|
| What makes it different | - No vendor spin or cherry-picked studies in reports
- Evidence scored by research quality, not advertising budget
- Covers 29 peptide compounds with detailed analysis
- Results delivered in seconds with full source traceability
- No medical advice: pure research summarization tool
| - Integrates records, wearables and genome in one place, not just one slice
- Re-analyzes raw sequencing data with genomic pipelines, not just summaries
- Licensed physician reviews every deeper analysis, not AI alone
- Funded by membership only, data never sold or used for advertising
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | Not checked yet ● no change since last check | 56 ▲ +1 (up) since last check |
|---|
| Trust Flow (Majestic) | 0 | 26 |
|---|
| Citation Flow (Majestic) | 10 | 28 |
|---|
| Referring domains (Majestic) | 11 | 78 |
|---|
PepGuard
Triangle